| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 41 |
| 1 | ADALIMUMAB | 28 |
| 2 | CYCLOPHOSPHAMIDE | 26 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 26 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 26 |
| 5 | GABAPENTIN | 24 |
| 6 | PACLITAXEL | 24 |
| 7 | ACETAMINOPHEN | 22 |
| 8 | ACETAMINOPHEN 500MG | 21 |
| 9 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 21 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ARIMOCLOMOL CITRATE | 1 | 0.0217 |
| 1 | ACETAMINOPHEN AND ASPIRIN AND CAFFEINE | 1 | 0.0062 |
| 2 | CABOTEGRAVIR SODIUM | 4 | 0.0025 |
| 3 | CALCIFEDIOL | 6 | 0.0024 |
| 4 | TAGRAXOFUSP | 1 | 0.0019 |
| 5 | SOTAGLIFLOZIN | 1 | 0.0018 |
| 6 | PERPHENAZINE | 3 | 0.0014 |
| 7 | MEMANTINE | 19 | 0.0014 |
| 8 | DISOPYRAMIDE PHOSPHATE | 1 | 0.0012 |
| 9 | ISATUXIMAB | 6 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 66 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 53 |
| 2 | Kinase Inhibitor [EPC] | 28 |
| 3 | Alkylating Drug [EPC] | 26 |
| 4 | Microtubule Inhibitor [EPC] | 25 |
| 5 | Loop Diuretic [EPC] | 24 |
| 6 | Proton Pump Inhibitor [EPC] | 24 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 22 |
| 8 | Dihydropyridine Calcium Channel Blocker [EPC] | 20 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 18 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD123 Interaction [EPC] | 1 | 0.0019 |
| 1 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 7 | 0.0012 |
| 3 | Endoglycosidase [EPC] | 2 | 0.0011 |
| 4 | Enzyme Stabilizer [EPC] | 1 | 0.0009 |
| 5 | Nucleoside Analog Antifungal [EPC] | 1 | 0.0007 |
| 6 | Blood Viscosity Reducer [EPC] | 2 | 0.0005 |
| 7 | Monobactam Antibacterial [EPC] | 1 | 0.0004 |
| 8 | Glucosylceramide Synthase Inhibitor [EPC] | 1 | 0.0004 |
| 9 | Provitamin D2 Compound [EPC] | 10 | 0.0003 |